Myriad Genetics (MYGN) – Upgrades
-
Goldman Sachs Upgrades Myriad Genetics (MYGN) to Buy, 'differentiated financial profile at a discount'
-
Raymond James Upgrades Myriad Genetics (MYGN) to Outperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MYGN Stock Lookup